Ischemia-Reperfusion Injury at the Microvascular Level
Authors:
- 19 December 2000
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 102 (25) , 3111-3116
Abstract
Background —The purpose of this study was to verify whether endothelin A–antagonist administration at the time of coronary reperfusion preserves postischemic microvasculature and whether myocardial contrast echo (MCE) is able to detect pharmacologically induced changes in microvascular reflow. Methods and Results —Twenty dogs underwent 90 minutes of LAD occlusion (OCC) followed by 180 minutes of reperfusion (RP). Five minutes before LAD reopening, an intravenous bolus (5 mg/kg) of LU 135252 was given in 10 dogs and vehicle in the remaining 10. At baseline (BSL), OCC, and 90 and 180 minutes of RP, microvascular flow (BF) was assessed by microspheres, and MCE was performed with intravenous echo contrast. MCE videointensity and BF were expressed as risk area/control ratio. Myocardial thickness of the risk area was calculated by 2D echo. No differences in BF between the 2 groups were observed at BSL, OCC, and 90 minutes of RP. At 180 minutes of RP, BF was decreased in controls (70±7.4% of BSL; P P =NS versus BSL; P P Conclusions —Endothelin A–antagonist treatment at the time of reperfusion significantly limited the progressive decrease in postischemic microvascular reflow and the increase in myocardial thickness. MCE allowed a reliable evaluation of pharmacologically induced changes in microvascular flow.Keywords
This publication has 18 references indexed in Scilit:
- Analysis of microvascular integrity, contractile reserve, and myocardial viability after acute myocardial infarction by dobutamine echocardiography and myocardial contrast echocardiographyThe American Journal of Cardiology, 1996
- Intravenous administration of the endothelin-1 antagonist BQ-123 does not ameliorate myocardial ischaemic injury following acute coronary artery occlusion in the dogCardiovascular Research, 1994
- Reperfusion enhances the local release of endothelin after regional myocardial ischemiaAmerican Heart Journal, 1994
- The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusionCardiovascular Research, 1993
- Endothelin-1 enhances vascular permeability in the rat heart through the ETA receptorEuropean Journal of Pharmacology, 1992
- Increased plasma endothelin-1 in the early hours of acute myocardial infarctionJACC, 1991
- Assessment of regional myocardial blood flow with myocardial contrast two-dimensional echocardiographyJACC, 1989
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988
- The injury-spasm (ischemia-induced hemostatic vasoconstrictive) and vascular autoregulatory hypothesis of ischemic diseaseThe American Journal of Cardiology, 1982
- The “No-Reflow” Phenomenon after Temporary Coronary Occlusion in the DogJournal of Clinical Investigation, 1974